MAPK3 and cancer: Extracellular signal-regulated kinase 1/2 (ERK1/2) activation is elevated in PSCs from PDAC when compared with PSCs from normal tissue, and inhibition of ERK1/2 in PSCs reduced EMT in pancreatic cancer cells and suppressed cancer-stromal interactions and metastasis [85].